The Global Fish Skin Disease Market Growth Accelerated By Rising Prevalence Of Fish Skin Diseases
Fish Skin Disease Market |
Fish skin disease are common microbial infections affecting skin of fishes which lead to physiological issues. Fish skin disease diagnostic assays help in early detection and treatment of fungal, bacterial and viral infections. The global fish skin disease market demand for diagnostic assays is growing due to rising prevalence of fungal and bacterial infections in aquaculture industry. With increasing fish farming practices, risk of diseases transmission is also high requiring regular diagnostics.
The
global Fish Skin Disease Market is estimated to be valued at US$ 1.84 Mn in 2023 and is expected to
exhibit a CAGR of 6.6% over the
forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of fish skin diseases is majorly driving the growth
of global fish skin disease market during the forecast period. Rising
commercial fish farming for food supply has increased the risk of infectious
diseases transmission among fishes living in dense populations. According to
OIE, bacterial skin ulcers caused by Flexibacter columnaris and Streptococcus
iniae remains one of the most prevalent and economically important bacterial
diseases affecting several fish species worldwide including salmon, trout and
tilapia. As per statistics, losses due to flexibacterial gill disease in farmed
salmon range from 5-15% of total production annually. Thus, increasing
prevalence of common fish diseases is expected to boost the diagnostics demand
over the forecast period.
Segment Analysis
The global fish skin disease market is dominated by the infections segment,
which accounted for nearly 30% share of the overall market in 2023. Fish skin
infections are common in aquaculture as fish are more susceptible to various
bacterial, viral, fungal and parasitic infections due to stress factors such as
overcrowding, poor water quality and sanitation. The increasing demand for
aquaculture products and rising adoption of intensive culture practices have
further accelerated the risk of infections in fish.
Key Takeaways
The Global
Fish Skin Disease Market Size is expected to witness high growth over
the forecast period. The global fish skin disease market is estimated to be
valued at US$ 1.84 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over
the forecast period 2023 to 2030,.
Regionally,
Asia Pacific dominated the global market with more than 35% share in 2023 owing
to the large aquaculture production in China and India. Rapid industrialization
of fish farming along with the low cost of production and lax implementation of
biosecurity measures have fueled the spread of various fish skin diseases in
the region.
Key players operating in the fish skin disease market are Glaxo Smith Kline
PLC., Isarna Therapeutics GmbH, Aptose Biosciences Inc., Regulus Therapeutics
Inc., and Rexahn Pharmaceuticals Inc. Glaxo Smith Kline PLC offers
anti-parasitic drugs for treating skin infections in aquaculture, while Isarna
Therapeutics GmbH provides RNA-based immunomodulatory therapeutics targeting
viral infections in fish. Researchers are also exploring RNA interference and
gene-silencing techniques to develop effective treatments against fungal and
bacterial pathogens.
Get
more insights on this topic:
Comments
Post a Comment